MLAB
Mesa Laboratories, Inc.
NASDAQ · Technology · Hardware, Equipment & Parts · US
$127.78
−0.58%Year over year
Reported trailing growth
- Revenue
- +3.0%
- EBITDA
- -9.2%
- EBIT
- +62.6%
- EPS
- +816.7%
- Free cash flow
- +66.8%
- Operating cash flow
- +45.5%
Forward estimates
Based on analyst estimates
- Revenue
- +3.0%
- EBITDA
- +124.7%
- EPS
- +858.9%
Three-year CAGR
- Revenue
- +4.4%
- EBITDA
- -2.0%
- EBIT
- +77.3%
- Net income
- +93.3%
- EPS
- +92.9%
- Free cash flow
- +19.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026